Introduction: Preventive resin restorations (PRR) are the conservative choice for the most common carious lesions in children. Thus, new age flowable resin composites with higher filler content are readily used. The aim of this study was to evaluate the microshear bond strength and microleakage of two flowable resin composites containing different percentages of nano zinc oxide (NZnO) particles, which have proven to have antimicrobial properties.

Methods: This experimental in-vitro study was carried out in the Dental Material Research Center of Babol University of Medical Sciences in 2015. One nanohybrid and one nanofill flowable resin composite were chosen and modified with the incorporation of 1% and 3% Wt NZnO particles. Six groups (n=10, 0%, 1%, and 3%) of resin composite sticks on dental enamel (2×2mm) were prepared to be placed in the microtensile tester. The microshear bond strength magnitude (MPa) was recorded at the point of failure. A class I box (3×0.8×1 mm) was prepared on 60 premolars and filled using the resin composites (6 groups, n=10). The specimens were immersed in a 5% basic fuschin solution and sectioned bucco-lingually to view the microleakage using a stereomicroscope. One-way ANOVA and Tukey tests for microshear and Wilcoxon and Kruskal–Wallis tests for microleakage were used to analyze the data in the IBM SPSS Statistics version 22 software.

Results: The bond strength of the 3% clearfill group significantly decreased while no significant change occurred in the bond strength in other groups. The Z-350 group had significantly lower microleakage as nanoparticles increased. No significant difference was observed in the clearfill group. 

Conclusion: Up to 3% Wt incorporation of NZnO particles will not diversely alter the bond strength, but it will be beneficial in providing antimicrobial effects with lower microleakage rates.


Keywords: Dental leakage; Flowable composite; Nanoparticles; Shear strength; Zinc oxide
» HTML Fulltext    » PDF Fulltext    » doi: 10.19082/3289

Latest Issue:

In October-December 2018, the journal publishes several original research, including an outstanding Prospective Cohort Study, some experimental studies, and an editorial on a topic of current interest in today’s medical research. Read more:


The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:


TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:

Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: